Biopharma AbbVie (ABBV) has announced positive Phase 3 data from a Select-Choice clinical trial, comparing Rinvoq (upadacitinib, 15 mg, once daily) to Bristol-Myers …
Bristol Myers Squibb (BMY) has announced positive results from True North, a pivotal Phase 3 trial evaluating oral Zeposia (ozanimod) as an induction and …
Bluebird Bio (BLUE) priced an offering of 9.09 million shares of its common stock at $55 each, the company said late on Monday.
Bluebird bio Inc. (BLUE) said on Monday its partner Bristol Myers Squibb Co.
Worth $23 billion today, former math professor Jim Simons has become one of the most successful money managers of all time. Following his …
Yesterday, Merck (NYSE:MRK) reported data from Keytruda in combo with chemotherapy for patients with non-small cell lung cancer (NSCLC). The data was positive …
Bristol-Myers Squibb Co (NYSE:BMY) announced the U.S.
There was more terrible economic news today as core durable goods orders fell for the 21st straight month which is the longest decline …
Bristol-Myers Squibb Co (NYSE:BMY) announced that the U.S.
Bristol-Myers Squibb Co (NYSE:BMY) announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended the approval …
